Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
[google_news title=”” keyword=”Shortages of life-saving drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Shortages of life-saving drugs
- A Looming Crisis - Kalungu District Grapples With Drug Shortageson April 27, 2024 at 5:04 am
A dark cloud hangs over Kalungu District, Uganda. Since January 2024, government health facilities have faced a critical shortage of essential drugs, leaving patients in a desperate scramble for ...
- Drug Shortages Compounded by Lack of Information, Transparencyon April 26, 2024 at 6:30 am
A lack of information on drug shortages can make it difficult to identify and respond to shortages appropriately, but improving supply chain transparency and federal oversight could reduce or prevent ...
- Life-saving medicines shortage hit many citieson April 25, 2024 at 8:28 am
KARACHI: A critical shortage of life-saving medicines has hit Pakistan, leaving patients in distress as 27 essential drugs, including insulin, vanish from shelves across the Pakistan.According to ...
- Drug shortages are ‘new normal’ and made worse by Brexit, report sayson April 18, 2024 at 8:21 am
Regular shortages of life-saving medicines have become the ‘new normal’ in the UK and Brexit has made the problem harder to tackle.
- What We’re Reading: Emergency Care Prices Vary; Drug Shortages at Record High; Asthma Medication Access Difficultieson April 18, 2024 at 8:02 am
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to ...
- Drug shortages, now normal in UK, made worse by Brexit, report warnson April 18, 2024 at 12:19 am
Some shortages are so serious they are imperilling the health and even lives of patients with serious illnesses, pharmacy bosses say ...
- Shortages of life saving medicines has become ‘new normal’ for UK after Brexiton April 17, 2024 at 8:10 pm
Shortages of life-saving medication such as antibiotics, epilepsy and cancer drugs compounded by Brexit have worsened the UK’s “ broken” supply chain, researchers have warned. The government has been ...
- Drug shortages at highest since 2014: Chemo drugs, Wegovy, ADHD medications affectedon April 17, 2024 at 6:33 pm
In the first quarter of the year 323 drugs were in shortage, surpassing the 2014 high of 320, the American Society of Health-System Pharmacists said.
- The link between America’s drug shortage crisis and supply chain challengeson April 13, 2024 at 2:59 am
America's drug shortage crisis is intricately linked to the complexities within the pharmaceutical supply chain. While the intuitive solution to this crisis mi ...
- How did Germany run low on potentially life-saving HIV medication?on April 13, 2024 at 12:20 am
There was a warning of a shortage of pre-exposure prophylaxis, or PrEP, as early as October before authorities said they were intervening in January.
via Bing News